• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    HCA Announces Proposed Public Offering of Senior Notes

    2/18/25 8:40:00 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care
    Get the next $HCA alert in real time by email

    HCA Healthcare, Inc. (NYSE:HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of borrowings outstanding under its existing or future senior credit facilities.

    BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Mizuho Securities USA LLC and Wells Fargo Securities, LLC are acting as the joint book-running managers for the offering.

    The offering of the senior notes is being made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission. The offering is being made only by means of a preliminary prospectus supplement and the accompanying prospectus, copies of which may be obtained by contacting BofA Securities, Inc., NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, Attn: Prospectus Department, by email: [email protected] or by telephone 1-800-294-1322; Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by email at [email protected] or telephone at 1-888-603-5847; Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone: 1-800-831-9146 or by email: [email protected]; J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York, 10179, Attention: Investment Grade Syndicate Desk, 3rd Floor, telephone collect at 1-212-834-4533; Mizuho Securities USA LLC, Attn: Debt Capital Markets, 1271 Avenue of the Americas, New York, New York 10020, or by calling toll-free at 1-866-271-7403; or Wells Fargo Securities, LLC, 608 2nd Avenue South, Suite 1000, Minneapolis, MN 55402, Attn: WFS Customer Service, by email: [email protected] or by telephone (toll-free): 1-800-645-3751.

    You may also visit www.sec.gov to obtain an electronic copy of the related preliminary prospectus supplement and the accompanying prospectus.

    This press release does not constitute an offer to sell or a solicitation of an offer to buy the senior notes or any other security and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which, or to any persons to whom, such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

    FORWARD-LOOKING STATEMENTS

    Information provided and statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this press release and HCA assumes no obligation to update the information included in this press release. Such forward-looking statements include the expected use of proceeds from the offering. These statements often include words such as "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan," "initiative" or "continue." These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about HCA's industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond HCA's control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance or occurrence of events and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Although HCA believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. More information about potential risks and uncertainties that could affect the Company's business and results of operations is included in the "Risk Factors" and "Forward-Looking Statements" sections in the Annual Report on Form 10-K filed by the Company with the SEC on February 14, 2025 and our other filings with the Securities and Exchange Commission. Unless otherwise required by law, HCA also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this press release.

    All references to the "Company" and "HCA" as used throughout this press release refer to HCA Healthcare, Inc. and its affiliates.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250217417970/en/

    INVESTOR CONTACT:

    Frank Morgan

    615-344-2688

    MEDIA CONTACT:

    Harlow Sumerford

    615-344-1851

    Get the next $HCA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HCA

    DatePrice TargetRatingAnalyst
    4/15/2025$336.00Outperform → Neutral
    Robert W. Baird
    12/17/2024$380.00Neutral
    Analyst
    11/25/2024$400.00 → $320.00Equal Weight → Underweight
    Wells Fargo
    11/22/2024Outperform → Mkt Perform
    Raymond James
    10/11/2024$475.00Overweight
    KeyBanc Capital Markets
    9/3/2024$427.00Equal-Weight
    Morgan Stanley
    5/30/2024$396.00Outperform
    Robert W. Baird
    3/6/2024$356.00Overweight
    Barclays
    More analyst ratings

    $HCA
    Financials

    Live finance-specific insights

    See more
    • HCA Healthcare Reports First Quarter 2025 Results

      HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2025. Key first quarter metrics (all percentage changes compare 1Q 2025 to 1Q 2024 unless otherwise noted): Revenues totaled $18.321 billion Net income attributable to HCA Healthcare, Inc. totaled $1.610 billion, or $6.45 per diluted share Adjusted EBITDA totaled $3.733 billion Cash flows from operating activities totaled $1.651 billion Same facility admissions increased 2.6 percent and same facility equivalent admissions increased 2.8 percent "The solid fundamentals we saw in our business the past several quarters continued into the first quarter of 2025," said

      4/25/25 7:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare, Inc. 1st Quarter 2025 Earnings Conference Call

      HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q 2025 Earnings Call When: Friday, April 25, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20250404757460/en/ INVESTOR CONTACT: Frank Morgan

      4/4/25 4:00:00 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Reports Fourth Quarter 2024 Results and Provides 2025 Guidance

      HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2024. Key fourth quarter metrics (all percentage changes compare 4Q 2024 to 4Q 2023 unless otherwise noted): Revenues totaled $18.285 billion Net income attributable to HCA Healthcare, Inc. totaled $1.438 billion, or $5.63 per diluted share (which includes an estimated $0.60 per diluted share unfavorable impact from Hurricanes Helene and Milton) Adjusted EBITDA totaled $3.712 billion Cash flows from operating activities totaled $2.559 billion Same facility admissions increased 3.0 percent and same facility equivalent admissions increased 3.1 percent "

      1/24/25 7:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    SEC Filings

    See more
    • SEC Form 10-Q filed by HCA Healthcare Inc.

      10-Q - HCA Healthcare, Inc. (0000860730) (Filer)

      5/1/25 4:30:20 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - HCA Healthcare, Inc. (0000860730) (Filer)

      4/29/25 4:39:03 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - HCA Healthcare, Inc. (0000860730) (Filer)

      4/25/25 7:48:16 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP and CFO Marks Mike A gifted 935 shares, received a gift of 647 shares, disposed of $203,529 worth of shares (573 units at $355.20) and acquired $203,529 worth of shares (573 units at $355.20), closing all direct ownership in the company (SEC Form 4)

      4 - HCA Healthcare, Inc. (0000860730) (Issuer)

      5/8/25 6:40:51 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • Director Frist William R was granted 1,026 shares and acquired $3,577,854 worth of shares (10,505 units at $340.60), increasing direct ownership by 9% to 12,931 units (SEC Form 4)

      4 - HCA Healthcare, Inc. (0000860730) (Issuer)

      5/1/25 7:30:55 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • Director Frist Thomas F Iii was granted 1,320 shares, increasing direct ownership by 10% to 14,817 units (SEC Form 4)

      4 - HCA Healthcare, Inc. (0000860730) (Issuer)

      5/1/25 6:49:02 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $HCA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • HCA Healthcare, Inc. to Present at May Healthcare Conference

      HCA Healthcare, Inc. (NYSE:HCA) is scheduled to present at the following healthcare conferences: May 13, 2025 at 9:20am PT at the Bank of America 2025 Healthcare Conference. A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company's website for the latest information. About HCA Healthcare Nashville-based HCA Healthcare is one of the nation's leading providers of healthcare services comprising 192 hospitals and ap

      5/5/25 4:30:00 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Reports First Quarter 2025 Results

      HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2025. Key first quarter metrics (all percentage changes compare 1Q 2025 to 1Q 2024 unless otherwise noted): Revenues totaled $18.321 billion Net income attributable to HCA Healthcare, Inc. totaled $1.610 billion, or $6.45 per diluted share Adjusted EBITDA totaled $3.733 billion Cash flows from operating activities totaled $1.651 billion Same facility admissions increased 2.6 percent and same facility equivalent admissions increased 2.8 percent "The solid fundamentals we saw in our business the past several quarters continued into the first quarter of 2025," said

      4/25/25 7:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • Two Large Clinical Trials Find a Highly Effective Method to Select Appropriate Antibiotics for Patients Hospitalized With Abdominal or Skin and Soft Tissue Infection

      Computerized alerts tailored to each patient help identify which antibiotic is best suited to treat patients hospitalized with common infections in two 92-hospital trials. Two large multi-state studies funded by the National Institutes of Health and led by the University of California, Irvine, Harvard Pilgrim Health Care Institute, and HCA Healthcare have found a highly effective method to improve antibiotic selection for patients who are hospitalized with abdominal or skin and soft tissue infection to reduce their risk of antibiotic resistance. Results were published in JAMA Surgery and JAMA Internal Medicine and highlighted at the Congress of the European Society of Clinical Microbiology

      4/10/25 1:00:00 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • Large owner Bank Of America Corp /De/ bought $88,208 worth of shares (3,436 units at $25.67) and sold $79,816 worth of shares (3,178 units at $25.12) (SEC Form 4)

      4 - HCA Healthcare, Inc. (0000860730) (Issuer)

      3/28/25 4:11:57 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HCA downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded HCA from Outperform to Neutral and set a new price target of $336.00

      4/15/25 9:26:09 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • Analyst resumed coverage on HCA with a new price target

      Analyst resumed coverage of HCA with a rating of Neutral and set a new price target of $380.00

      12/17/24 8:04:06 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA downgraded by Wells Fargo with a new price target

      Wells Fargo downgraded HCA from Equal Weight to Underweight and set a new price target of $320.00 from $400.00 previously

      11/25/24 7:44:35 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Leadership Updates

    Live Leadership Updates

    See more
    • HCA Healthcare Announces HCA Healthcare Foundation's Support of Girl Scouts Mental Wellness Patch Programs

      HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation has helped Girl Scouts of the USA (GSUSA) launch a new series of Mental Wellness Patch Programs to address mental wellness among girls in 4th through 12th grade. This is a result of the HCA Healthcare Foundation's $1.38 million grant to GSUSA, through its Healthier Tomorrow Fund, which was announced last year. "The HCA Healthcare Foundation has a long history of partnering with Girl Scouts nationally and locally. We are proud to deepen our partnership with Girl Scouts on this research-based mental wellness program," said Joanne Pulles, vice president of com

      9/19/23 8:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Appoints Jyric Sims President of Company's West Florida Division

      HCA Healthcare, Inc. (NYSE:HCA) today announced Jyric Sims, Ph.D., will become president of the company's West Florida Division, effective June 12. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230420005364/en/Jyric Sims, Ph.D. (Photo: Business Wire) Sims, who currently is CEO of HCA Healthcare's Medical City Plano and Medical City Frisco hospitals, will succeed Ravi Chari, M.D., who recently announced he will retire after 15 years with the company to pursue opportunities in early-stage healthcare companies. A more than 20-year healthcare veteran, Sims has been with HCA Healthcare since 2011. He has served as chief executive

      4/20/23 8:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Announces Retirement of Longtime Senior Executive Chuck Hall

      HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Chuck Hall, HCA Healthcare's National Group president, will retire at the end of the year after nearly 36 years with the organization. Currently, Hall is responsible for HCA Healthcare's operations at 96 hospitals across 13 states. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220817005233/en/HCA Healthcare Announces Retirement of Longtime Senior Executive Chuck Hall (Photo: Business Wire) Over more than three decades, Hall has been influential in many successful initiatives that will benefit the company for years to come, inc

      8/17/22 8:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)

      SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)

      2/14/24 5:10:03 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)

      SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)

      2/14/24 5:06:57 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)

      SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)

      2/13/24 5:06:27 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care